Summary
For Year 2026-27, Dr Reddy's Laboratories. reports the following shareholding: Total Promoters at 26.63%, Mutual Fund at 13.19%, Insurance at 14.64%, Foreign Institutional Investors at 21.14%, Domestic Institutional Investors at 2.89%, and Retail at 9.57%. This breakdown provides a quick snapshot of ownership distribution for Dr Reddy's Laboratories. in 2026-27.
Dr Reddy's Laboratories. FAQs
As of 04-2026, the promoter shareholding in Dr Reddy's Laboratories. stands at 26.63% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.
The FII and DII shareholding of Dr Reddy's Laboratories. is 21.14% and 2.89% respectively.
The retail shareholding of the Dr Reddy's Laboratories. is 9.57%.
Changes in shareholding patterns of Dr Reddy's Laboratories. can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.
Shareholding patterns of Dr Reddy's Laboratories. are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.
The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.
Dr Reddy's Laboratories. Associated Pages
- Dr Reddy's Laboratories. Share Price
- Dr Reddy's Laboratories. Share Price chart
- Dr Reddy's Laboratories. Fundamental Analysis
- Dr Reddy's Laboratories. Technical Analysis
- Dr Reddy's Laboratories. Peer Comparison
- Dr Reddy's Laboratories. Share Price History
- Dr Reddy's Laboratories. Dividend
- Dr Reddy's Laboratories. Board of Directors
